California Public Employees Retirement System maintained its position in NanoString Technologies, Inc. (NASDAQ:NSTG) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,000 shares of the biotechnology company’s stock at the end of the first quarter. California Public Employees Retirement System owned about 0.13% of NanoString Technologies worth $576,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of NSTG. Wellington Management Group LLP increased its position in NanoString Technologies by 6.8% in the first quarter. Wellington Management Group LLP now owns 509,051 shares of the biotechnology company’s stock valued at $10,115,000 after buying an additional 32,541 shares during the period. Spark Investment Management LLC boosted its position in shares of NanoString Technologies by 71.1% in the first quarter. Spark Investment Management LLC now owns 258,300 shares of the biotechnology company’s stock valued at $5,132,000 after buying an additional 107,300 shares in the last quarter. American International Group Inc. boosted its position in shares of NanoString Technologies by 7.4% in the first quarter. American International Group Inc. now owns 9,153 shares of the biotechnology company’s stock valued at $182,000 after buying an additional 634 shares in the last quarter. Eagle Global Advisors LLC purchased a new position in shares of NanoString Technologies during the first quarter valued at about $360,000. Finally, Strs Ohio boosted its position in shares of NanoString Technologies by 4.2% in the first quarter. Strs Ohio now owns 32,600 shares of the biotechnology company’s stock valued at $647,000 after buying an additional 1,300 shares in the last quarter. 90.10% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NanoString Technologies, Inc. (NASDAQ:NSTG) traded up 0.94% on Monday, hitting $14.01. 35,609 shares of the stock traded hands. NanoString Technologies, Inc. has a 52-week low of $13.17 and a 52-week high of $23.45. The firm’s market cap is $353.11 million. The firm has a 50 day moving average price of $15.39 and a 200 day moving average price of $17.51.

NanoString Technologies (NASDAQ:NSTG) last released its earnings results on Tuesday, August 8th. The biotechnology company reported ($0.20) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.17. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. The business had revenue of $34.59 million for the quarter, compared to analyst estimates of $29.87 million. On average, equities analysts forecast that NanoString Technologies, Inc. will post ($2.12) EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/08/21/california-public-employees-retirement-system-maintains-stake-in-nanostring-technologies-inc-nstg.html.

Several research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of NanoString Technologies from a “buy” rating to a “hold” rating in a report on Saturday, August 12th. BidaskClub cut shares of NanoString Technologies from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th. Cowen and Company restated a “buy” rating on shares of NanoString Technologies in a report on Friday, July 14th. Finally, ValuEngine cut shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $18.50.

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.